Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19.

The Journal of Clinical Endocrinology and Metabolism
Shivani AgarwalRobert A Gabbay

Abstract

The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this "new normal" state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.

References

Mar 9, 2011·Journal of the American Pharmacists Association : JAPhA·Leticia R MoczygembaGary R Matzke
Apr 26, 2013·The New England Journal of Medicine·Mohammed K AliEdward W Gregg
Apr 29, 2015·International Journal of Clinical Pharmacy·Emina ObarcaninStephanie Läer
May 23, 2015·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network
May 14, 2016·Journal of Diabetes Science and Technology·Winnie LiuNeda Rasouli
Aug 5, 2016·Academic Medicine : Journal of the Association of American Medical Colleges·Carrol ZhouSanjeev Sockalingam
Aug 24, 2016·Current Diabetes Reports·Matthew F BouchonvilleSanjeev Arora
Jun 16, 2017·Journal of Telemedicine and Telecare·Jonas KwokDelphine S Tuot
May 26, 2018·JAMA Internal Medicine·Michelle S LeeMichael L Barnett
Oct 24, 2018·Journal of Diabetes Science and Technology·Payal S PatelMadhuri M Vasudevan

❮ Previous
Next ❯

Citations

Jun 8, 2021·Expert Review of Endocrinology & Metabolism·Aman RajpalDavid C Aron
Jun 16, 2021·The Journal for Nurse Practitioners : JNP·Susan J AppelMudasir S Andrabi

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

eConsults

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
Viswanathan Mohan, Venkatesan Radha
Clinical Diabetes : a Publication of the American Diabetes Association
Olivia Z B GinnardDaniel J DeSalvo
Endocrinology and Metabolism Clinics of North America
Magdalene M Szuszkiewicz-Garcia, Jaime A Davidson
© 2021 Meta ULC. All rights reserved